StreetInsider.com News Articles

Covalon Showcases Contamination Protection Solution at ANCC Magnet & Pathway 2026 Conference

Tue, 27 Oct 2026 17:01:00 -0500

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company today announced its upcoming participation in the 2026 American Nurses Credentialing Center (ANCC) National Magnet® & Pathway to Excellence Conference™, taking place October 29 – 31, 2026 in Chicago, Illinois.

Magnet® designation is the highest level of recognition for nursing excellence and quality patient care. Healthcare organizations that earn Magnet® status are acknowledged for their commitment to exceptional nursing practice, strong patient outcomes, and a culture of continuous improvement. The annual conference attracts nurses and healthcare leaders from around

Covalon Showcases Contamination Protection Solution at ANCC Magnet & Pathway 2026 Conference

Tue, 27 Oct 2026 17:01:00 -0500

Covalon Showcases Contamination Protection Solution at ANCC Magnet & Pathway 2026 Conference

Tue, 27 Oct 2026 17:01:00 -0500

Covalon Showcases Contamination Protection Solution at ANCC Magnet & Pathway 2026 Conference

Tue, 27 Oct 2026 17:01:00 -0500

Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting

Mon, 28 Sep 2026 07:00:00 -0500

Meeting to be held October 2 - 4, 2026, at the Gaylord Texan Resort & Convention Center in Grapevine, Texas, with pre-meeting workshops on October 1

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation at the Association for Vascular Access (AVA) Annual Scientific Meeting in Grapevine, Texas, from October 2 to 4, 2026, with pre-meeting workshops on October 1. Attendees will have the opportunity to explore Covalon’s innovative vascular access and infection prevention solutions and learn why leading hospitals in the United

Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting

Mon, 28 Sep 2026 07:00:00 -0500

Meeting to be held October 2 - 4, 2026, at the Gaylord Texan Resort & Convention Center in Grapevine, Texas, with pre-meeting workshops on October 1

Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting

Mon, 28 Sep 2026 07:00:00 -0500

Meeting to be held October 2 - 4, 2026, at the Gaylord Texan Resort & Convention Center in Grapevine, Texas, with pre-meeting workshops on October 1

Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting

Mon, 28 Sep 2026 07:00:00 -0500

Meeting to be held October 2 - 4, 2026, at the Gaylord Texan Resort & Convention Center in Grapevine, Texas, with pre-meeting workshops on October 1

Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings

Thu, 24 Sep 2026 07:00:00 -0500

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced encouraging findings from a retrospective real world evidence analysis of collagen advanced wound care dressings conducted with Intellicure LLC, a highly respected wound care data analytics firm.

The analysis used de-identified records from the US Wound Registry and a Bayesian ordinal model to estimate the probability of reaching substantial granulation coverage at four, eight, and twelve weeks in patients with diabetic foot ulcers and venous leg ulcers that presented with no granulation tissue at baseline. Wounds were

Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings

Thu, 24 Sep 2026 07:00:00 -0500

Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings

Thu, 24 Sep 2026 07:00:00 -0500

Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings

Thu, 24 Sep 2026 07:00:00 -0500

Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%

Tue, 22 Sep 2026 07:00:00 -0500

Presentation at 10:00 a.m. PT / 1:00 p.m. ET on Monday, September 28, 2026

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company today announced that it will present at the 2026 Annual Smallcap Discoveries Conference, being held at the JW Marriott Parq in Vancouver, British Columbia, Canada on September 28 and 29, 2026.

Brent Ashton, Covalon’s Chief Executive Officer, will present on Monday, September 28, 2026, at 10:00 a.m. PT (1:00 p.m. ET) and will also participate in one-on-one meetings with investors during the conference.

The presentation follows

Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%

Tue, 22 Sep 2026 07:00:00 -0500

Presentation at 10:00 a.m. PT / 1:00 p.m. ET on Monday, September 28, 2026

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company today announced that it will present at the 2026 Annual Smallcap Discoveries Conference, being held at the JW Marriott Parq in Vancouver, British Columbia, Canada on September 28 and 29, 2026.

The presentation follows

Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%

Tue, 22 Sep 2026 07:00:00 -0500

Presentation at 10:00 a.m. PT / 1:00 p.m. ET on Monday, September 28, 2026

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company today announced that it will present at the 2026 Annual Smallcap Discoveries Conference, being held at the JW Marriott Parq in Vancouver, British Columbia, Canada on September 28 and 29, 2026.

The presentation follows

Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%

Tue, 22 Sep 2026 07:00:00 -0500

Presentation at 10:00 a.m. PT / 1:00 p.m. ET on Monday, September 28, 2026

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company today announced that it will present at the 2026 Annual Smallcap Discoveries Conference, being held at the JW Marriott Parq in Vancouver, British Columbia, Canada on September 28 and 29, 2026.

The presentation follows

Covalon Reports Fiscal 2026 Third Quarter Results